他汀类药对稳定期不同程度老年COPD患者下呼吸道细菌定植的影响

孟鸿琼; 苏慧鹏; 龙琼华; 王婷婷; 胡阳

他汀类药对稳定期不同程度老年COPD患者下呼吸道细菌定植的影响

昆明医科大学附属延安医院老年病科

基金项目:

基金：云南省教育厅科学研究基金资助项目 (2014Y164);

计量
- 文章访问数: 1663
- HTML全文浏览量: 631
- PDF下载量: 30
- 被引次数: 0
出版历程
- 收稿日期: 2018-02-09

Effect of Statins on Lower Airway Bacterial Colonization in Elderly Patients with Stable Chronic Obstructive Pulmonary Disease of Different Severity

Funds:

基金：云南省教育厅科学研究基金资助项目 (2014Y164);

摘要

摘要: 目的探讨稳定期不同程度老年COPD患者下呼吸道细菌定植的细菌学变化特点, 及其与急性加重、炎性反应、肺功能损害之间的关系, 从而研究他汀类药对稳定期老年COPD患者LABC的影响.方法选择稳定期老年COPD患者96例, 进行痰液及支气管肺泡灌洗液 (BALF) 细菌学定量, 定性分析, 根据结果分为LABC阳性联合他汀治疗、常规治疗组及LABC阴性联合他汀治疗组及常规治疗组, 测定实验前后血清白介素6 (IL-6) 、白介素8 (IL-6) 、hs-CRP及TNF-α水平及肺功能.结果 87例患者有40例存在LABC (45.98%) , LABC阳性患者血清IL-6, IL-8, TNF-α、hs-CRP高于LABC阴性 (P<0.05) , 肺功能较LABC阴性明显下降 (P<0.05) , 随访1 a联合他汀治疗组血清IL-6, IL-8, TNF-α、hs-CRP低于常规治疗组 (P<0.05) ;肺功能改善优于常规治疗组 (P>0.05) ;急性加重风险低于常规治疗组 (P<0.05) ;LABC阳性患者联合他汀治疗组抑制细菌定植高于常规治疗组 (P<0.05) ;LABC阴性患者联合他汀治疗组细菌定植低于常规治疗组.结论稳定期老年COPD患者LABC阳性患者血清IL-6, IL-8, TNF-α、hs-CRP高于LABC阴性者, 联合他汀治疗有利于抑制LABC或增殖, 减轻炎性反应, 减少急性加重, 延缓肺功能下降, 改善临床症状.
- 老年稳定期COPD /
- 下呼吸道细菌定植 /
- 他汀类药 /
- 炎性因子 /
- 肺功能
Abstract: Objective To explore the effect of statins on lower airway bacterial colonization (LABC) in elderly patients with stable chronic obstructive pulmonary disease (COPD) of different severity by analyzing the bacteriological changes of LABC in those patients and its relationship with acute exacerbation, inflammatory reaction and lung function impairment.Methods A total of 96 patients with stable COPD were enrolled and quantitative and qualitative bacteriological analysis of patients' sputum and bronchoalveolar lavage fluid (BALF) were performed.According to the test results, patients were divided into four groups: patients with LABC positive receiving statin treatment, patients with LABC positive receiving conventional therapy, patients with LABC negative receiving statin treatment, and patients with LABC negative receiving conventional therapy.The serum levels of IL-6, IL-8, hs-CRP, TNF-α and lung function were examined before and after the experiment.Results There were 40 patients with LABC positive in 96 patients, with bacterial colonization rate of 45.98%.The serum level of IL-6, IL-8, TNF-α and hs-CRP in patients with LABC positive were significantly higher than those in patients with LABC negative (P <0.05) .Lung function in patients with LABC positive was significantly poorer than that in patients with LABC negative (P <0.05) .One-year follow-up showed that the serum levels of IL-6, IL-8, TNF-α and hs-CRP in patients with statin treatment were significantly lower than those in patients with conventional therapy (P<0.05) and better improvements of lung function were observed in patients with statin treatment (P>0.05) .The risk of acute exacerbation in patients with statin treatment was significantly higher than those in patients with conventional treatment (P<0.05) .The bacteria engraftment rate of the patients with LABC positive receiving statin treatment was significantly higher than that in patients with conventional therapy (P<0.05) while it was lower in the patients with LABC negative receiving statin treatment.Conclusion The levels of IL-6, IL-8, TNF-α, hs-CRP in elderly patients with stable COPD and LABC positive are higher than those with LABC negative.Treatment combined with statins helps to inhibit LABC or proliferation, reduce inflammatory reaction and acute exacerbation, delay the decline of lung function, and improve clinical symptoms.
- Elderly stable COPD /
- Lower airway bacterial colonization /
- Statins /
- Inflammatory factor /
- Lung function

HTML全文

参考文献(13)

[1]	[1]ZALACAIN R, SOBMDILLO V, AMILIBI8 J, et a1.Predisposing factors to bacterial colonization in chro Ilic obstructive pu Imonary disease[J].Eur Respir J, 1999, 13 (1) :343-348.
[2]	[2]MONSO E, ROSEU A, BONET G, et al.Risk factors for lower airway bacterial colonization in chronic bronchitis[J].Eur Respir J, 1999, 13 (1) :338-342.
[3]	[3]SANJAY SETHI, TIMOTHY F.Murphy.Bacterial infection in chronic obstructive plumonary disease in2000:a state-of-the-art review[J].Clinic Microbiology Reviews, 2001, 14 (2) :336-363.
[4] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组畅中华医学会呼吸分会慢性阻塞性肺疾病诊治指南 (2013年修订版) [J].中华结核和呼吸杂志, 2013, 36 (4) :255-264.
[5]	[5]SOLER N.EWIG S, TORRES A, et al.Airwayinnammation and bronchial microbia I pattems in patients with stable chronic obstl、Jctive pulmonary disease[J].Eur Respir J, 2001, 14 (3) :1015-1022.
[6]	[6]LOUKIDES S, BARTZIOKAS K, VESTBO J, etal.Novel anti-inflammatory agents in COPD:targeting lungand systemic inflammation[J].Curr Drug Targets, 2013, 14 (26) :235-245.
[7]	[7]KIM D Y.RYU S Y, LIM J E, et a1.Anti inflammatory mechanism of simvastatin in mouse allergic asthma model[J].Eur J Pharmacol, 2007, 557 (7) :76-86.
[8]	[8]SOYSETH V, BREKKE PH, SMITH P, et al.Statin use is associated with reduced.mortality in COPD[J].Eur Respir J, 2007, 29 (2) :279-283.
[9]KEDDISSI儿, YOUNIS WG, CHBEIR EA, et a1.The use of statins and lung function incurrent and former smokers[J].Chest, 2007, 13 (2) :1764-1767.
[10]	[10]ALEXEEFF S E.LITONJUA A A, SPARROW D, et al.Statin UM reduces decline in lung function:VA normative aging study[J].Am J Respir Ctit Care Med, 2007, 176 (1) :742-747.
[11]	[11]WRIGHT J L, ZHOU S, PREOBRAZHENSKA O, et al.Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling[J].Am J Respir Care Med, 2011, 183 (6) :50-58.
[12]	[12]LAHOUSSEL, LOTH DW, JOOS GF, et al.Statins, systemic inflammation and risk of death in COPD:the otterdam study[J].Pulm Pharmacol&The rapeutics, 2013, 26 (2) :212-217.
[13]	[13]CRINER GJ, CONNETT JE, AARON SD, etal.Simvastatin for the preventiong of exacerbations in moderate-to-severe COPD[J].N Engl J Med, 2014, 370 (23) :2201-2210.

相关文章(20)

[1]	王亚敏, 李媛媛, 薛艳云. 基于脑血流动力学、炎性因子探究银杏叶注射液联合多奈哌齐治疗阿尔茨海默病的临床疗效, 昆明医科大学学报.
[2]	丁文淞, 屈启才, 李鸿, 杨柳, 陶建平, 思永玉. 不同液体复苏对失血性休克兔微循环及炎性因子的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231202
[3]	李柯蓉, 赵智, 陈茉弦, 敖丽娟, 孟繁媛. 轻中度青少年特发性脊柱侧弯患者肺功能与呼吸肌力分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230707
[4]	李琳霞, 李艳红, 吴洁, 张黎黎, 张娴, 王松, 张俊涛, 燕鹏. 喘憋性肺炎婴幼儿血清维生素A、D与肺功能的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220114
[5]	黄倩, 李梅华, 汤晓静, 马葳, 杨艳霞, 郑勤玲, 和瑾. 慢阻肺患者肺功能与HRCT支气管壁厚度的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220224
[6]	邢正江, 李亚雄, 邹弘麟, 于振坤, 李文俊, 唐云, 贾政. 局部枸橼酸抗凝对体外循环心脏术后AKI患者NLRP-3及下游炎性因子表达的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211221
[7]	丁臻博, 鲁萍, 黄永坤, 赵亚玲, 罗艳, 段晶. 孟鲁司特钠与西替利嗪联合布地奈德治疗儿童咳嗽变异性哮喘临床效果、肺功能及安全性, 昆明医科大学学报.
[8]	朱晓霞, 戴路明. 吸氧对COPD稳定期患者肺康复治疗的影响, 昆明医科大学学报.
[9]	张黎. 活性维生素D3干预高原老年人骨骼肌减少症的相关因素, 昆明医科大学学报.
[10]	张洋. AECOPD患者治疗前后痰和血清IL-8、MMP-9的变化及其与肺功能的关系, 昆明医科大学学报.
[11]	毕虹. 昆明地区慢性阻塞性肺疾病患者肺功能影响因素分析, 昆明医科大学学报.
[12]	贺小玉. 慢性阻塞性肺疾病患者SAA及IP-10与炎性因子水平相关性分析, 昆明医科大学学报.
[13]	张继华. 慢性阻塞性肺疾病患者肺泡灌洗液SIgA表达水平与肺功能相关性研究, 昆明医科大学学报.
[14]	苏慧鹏. 老年慢性阻塞性肺疾病患者踝-臂脉搏波传导速度、踝臂指数的相关性, 昆明医科大学学报.
[15]	秦敏丽. RBP4与炎性因子水平对2型糖尿病下肢动脉病变的诊断价值, 昆明医科大学学报.
[16]	许霞. 回收式自体输血对患者炎性因子及ICAM-1、MMP-9的影响, 昆明医科大学学报.
[17]	丁艳杰. 类风湿患者血清颈动脉硬化与炎性因子相关性分析, 昆明医科大学学报.
[18]	张洋. 多发伤患者CT肺功能成像的临床应用研究, 昆明医科大学学报.
[19]	师国强. 支气管哮喘患者炎性因子水平与气道重构关系探讨, 昆明医科大学学报.
[20]	秦敏丽. 不同焦虑状态对糖尿病患者炎性因子及血管内皮功能的影响, 昆明医科大学学报.